Myositis 17 Antigen Panel
Test Code
MYOS
Description
Myositis is a disease characterized by inflammation of the muscles and is often associated with severe muscle weakness. The most common forms of myositis are polymyositis and dermatomyositis.
The presence of myositis-specific autoantibodies in patients can often be indicative of disease. This panel assays for myositis-specific and myositis-associated autoantibodies to 17 antigens, including several anti-tRNA synthetase autoantibodies. The panel may be used as an important part of the evaluation in those patients with myositis or select cases of idiopathic interstitial pneumonia. The 17 autoantibody specificities detected with the panel are associated with a range of inflammatory muscle diseases.
Collect
Collect in a plain red top or SST tube.
Pediatric Collection
Minimum volume: 0.1 mL
Storage Transport Temp
Send serum Priority Overnight via FedEx and in a well insulated container frozen on dry ice.
Stability
Frozen at -70°C: 1 year. Serum samples may be stored at +2°C to +8°C for up to 14 days if necessary.
Notes
National Jewish Health Advanced Diagnostic Laboratories offer a Myositis Antigen Panel to aid in the diagnosis of the idiopathic inflammatory myopathies, commonly referred to as myositis. When combined with clinical features, the Myositis Antigen Panel can aid clinicians in making a diagnosis of myositis, polymyositis, dermatomyositis, anti-synthetase syndrome and related conditions. The Myositis Antigen Panel provides a qualitative in vitro assay for human antibodies present in serum of the IgG class to 17 different antigens.
Performed
Monday - Friday
Methodology
Immunoblot
Turnaround Time
2-12 days
Department
Immunology Lab - Diagnostic
Synonyms
Mi-2 alpha, Mi-2 beta, Ku, PM-Scl100, PM-Scl75, Jo-1, SRP, PL-7, PL-12, EJ, OJ, Ro-52, TIF1 gamma, MDA5, NXP2, SAE1, cN-1A
Study Offerings
RUO
CAP/CLIA
Reference Interval
Negative 0-5 Units
Borderline 6-10 Units
Positive 11-50 Units
Strong Positive >50 Units
Interpretation
Antibodies to the antigens are determined by an immunoblot assay. The color developed for each antigen is determined by densitometry and the intensity of the color is proportional to the antibody reactivity. The results are given in arbitrary intensity units.
CPT Code
84182 x 17
New York Approved
No: Run with Waiver
FDA
LDT